{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:15:20Z","timestamp":1792012520244,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.01.018","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T17:39:03Z","timestamp":1421429943000},"page":"1235-1242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: A systematic review and implications for polio eradication"],"prefix":"10.1016","volume":"33","author":[{"given":"Jean","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bolivar-Wagers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Holubar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.018_bib0390","article-title":"OPV vs IPV: past and future choice of vaccine in the global polio eradication program","author":"Liu","year":"2003","journal-title":"Partn Health Reform Proj"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biologicals.2006.03.005","article-title":"A vision of a world without polio: the OPV cessation strategy","volume":"34","author":"Heymann","year":"2006","journal-title":"Biologicals"},{"issue":"24","key":"10.1016\/j.vaccine.2015.01.018_bib0400","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMp1104329","article-title":"The polio endgame","volume":"364","author":"Aylward","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.018_bib0405","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/infdis\/jiq148","article-title":"Eradication of poliovirus: fighting fire with fire","volume":"203","author":"Nathanson","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2249-4863.104936","article-title":"Polio eradication: current status and challenges","volume":"1","author":"Bhaumik","year":"2012","journal-title":"J Family Med Prim Care"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0415","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2014.864563","article-title":"National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication","volume":"13","author":"Thompson","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"26","key":"10.1016\/j.vaccine.2015.01.018_bib0420","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2010.04.001","article-title":"Optimal vaccine stockpile design for an eradicated disease: application to polio","volume":"28","author":"Duintjer Tebbens","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0425","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/risa.12044","article-title":"Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0430","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.018_bib0440","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of possible future global policies for managing polioviruses","volume":"98","author":"Thompson","year":"2008","journal-title":"Am J Public Health"},{"issue":"38","key":"10.1016\/j.vaccine.2015.01.018_bib0445","first-page":"358","article-title":"Update on vaccine-derived polioviruses detected worldwide, April 2011\u2013June 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"5566","key":"10.1016\/j.vaccine.2015.01.018_bib0450","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.018_bib0455","first-page":"41","article-title":"Circulation of a type 2 vaccine-derived poliovirus \u2013 Egypt, 1982\u20131993","volume":"50","author":"Center for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"10.1016\/j.vaccine.2015.01.018_bib0460","first-page":"622","article-title":"Public health dispatch: poliomyelitis\u2014Madagascar, 2002","volume":"51","author":"Center for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0465","series-title":"Global Polio Eradication Initiative","author":"Vaccine-derived Polioviruses (VDPV)","year":"2013"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0470","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biologicals.2006.02.005","article-title":"Vaccine-derived poliovirus from long term excretors and the end game of polio eradication","volume":"34","author":"Mart\u00edn","year":"2006","journal-title":"Biologicals"},{"issue":"20","key":"10.1016\/j.vaccine.2015.01.018_bib0475","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0480","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.01.018_bib0485","first-page":"33","article-title":"Emerging\/disappearing viruses future issues concerning polio eradication","volume":"82","author":"Minor","year":"2002","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0490","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Anal"},{"issue":"5","key":"10.1016\/j.vaccine.2015.01.018_bib0495","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/erv.12.28","article-title":"Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis","volume":"11","author":"Pliaka","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"28","key":"10.1016\/j.vaccine.2015.01.018_bib0500","first-page":"641","article-title":"Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis","volume":"46","author":"Center for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"10.1016\/j.vaccine.2015.01.018_bib0505","first-page":"1053","article-title":"Poliovirus infections in four unvaccinated children \u2013 Minnesota, August\u2013October 2005","volume":"54","author":"Center for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"40","key":"10.1016\/j.vaccine.2015.01.018_bib0510","first-page":"1093","article-title":"Update on vaccine-derived polioviruses","volume":"55","author":"Center for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"38","key":"10.1016\/j.vaccine.2015.01.018_bib0515","first-page":"996","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, January 2006\u2013August 2007","volume":"56","author":"Center for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"10.1016\/j.vaccine.2015.01.018_bib0520","first-page":"1002","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, January 2008\u2013June 2009","volume":"58","author":"Center for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"25","key":"10.1016\/j.vaccine.2015.01.018_bib0525","first-page":"846","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, July 2009\u2013March 2011","volume":"60","author":"Center for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"42","key":"10.1016\/j.vaccine.2015.01.018_bib0530","first-page":"398","article-title":"Vaccine-derived polioviruses \u2013 update","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"38","key":"10.1016\/j.vaccine.2015.01.018_bib0535","first-page":"390","article-title":"Vaccine-derived polioviruses detected worldwide January 2008\u2013June 2009","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"27","key":"10.1016\/j.vaccine.2015.01.018_bib0540","first-page":"277","article-title":"Vaccine-derived polioviruses detected worldwide, July 2009\u2013March 2011","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.018_bib0545","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.018_bib0550","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2003.11.011","article-title":"Search for poliovirus long-term excretors among patients affected by agammaglobulinemia","volume":"111","author":"Fiore","year":"2004","journal-title":"Clin Immunol"},{"issue":"36","key":"10.1016\/j.vaccine.2015.01.018_bib0555","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.vaccine.2012.06.017","article-title":"The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh","volume":"30","author":"Sazzad","year":"2012","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2015.01.018_bib0560","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1016\/j.vaccine.2012.10.035","article-title":"Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka","volume":"30","author":"de Silva","year":"2012","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2015.01.018_bib0565","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0264-410X(98)80025-X","article-title":"Surveillance of suspected poliomyelitis in Albania, 1980\u20131995: suggestion of increased risk of vaccine associated poliomyelitis","volume":"16","author":"Diamanti","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.018_bib0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12016-011-8292-9","article-title":"The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy","volume":"42","author":"van de Ven","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0575","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3201\/eid1404.070439","article-title":"Potential use of antiviral agents in polio eradication","volume":"14","author":"De Palma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0580","series-title":"The task force for global health. Polio Antivirals Initiative","year":"2014"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0585","series-title":"Presentation at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"Anti-poliovirus activity of pocapavir in a human mopv1 challenge model","author":"Collett","year":"2013"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0590","series-title":"Presented at the Polio Eradication Symposium, Infectious Diseases (ID) Week","article-title":"Antiviral drugs for poliomyelitis","author":"Modlin","year":"2013"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0595","series-title":"Income levels. World Bank's Annu World Dev Rep","year":"2013"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0600","series-title":"Nelson textbook of pediatrics","first-page":"715","article-title":"Chapter 116: Evaluation of suspected immunodeficiency","author":"Buckley","year":"2012"},{"issue":"12","key":"10.1016\/j.vaccine.2015.01.018_bib0605","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1086\/379791","article-title":"Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis","volume":"188","author":"Khetsuriani","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.018_bib0610","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3201\/eid1607.091606","article-title":"Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995\u20132008","volume":"16","author":"Shahmahmoodi","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0615","series-title":"R: a language and environment for statistical computing","isbn-type":"print","author":"R Core Team","year":"2013","ISBN":"https:\/\/id.crossref.org\/isbn\/3900051070"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0620","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(71)80313-X","article-title":"Vaccine-related paralytic poliomyelitis in an immunodeficient child","volume":"79","author":"Feigin","year":"1971","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0625","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-3476(74)80667-0","article-title":"Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease","volume":"84","author":"Lopez","year":"1974","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0630","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3476(75)80216-2","article-title":"Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia","volume":"86","author":"Saulsbury","year":"1975","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2015.01.018_bib0635","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM197708042970503","article-title":"Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child","volume":"297","author":"Davis","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.018_bib0640","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0022-3476(77)81309-7","article-title":"Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia","volume":"91","author":"Wright","year":"1977","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0645","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(86)80920-9","article-title":"Neurologic complications in oral polio vaccine recipients","volume":"108","author":"Gaebler","year":"1986","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0650","first-page":"363","article-title":"Congenital immunodeficiency revealed by an acute anterior poliomyelitis. A case report","volume":"60","author":"Benabdellah","year":"2000","journal-title":"Med Trop (Mars)"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0655","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/JVI.79.2.1062-1070.2005","article-title":"Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine","volume":"79","author":"Cherkasova","year":"2005","journal-title":"J Virol"},{"issue":"Pt (5)","key":"10.1016\/j.vaccine.2015.01.018_bib0660","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1099\/vir.0.18974-0","article-title":"Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis","volume":"84","author":"Buttinelli","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0665","series-title":"Vaccines","first-page":"598","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2012"},{"issue":"24","key":"10.1016\/j.vaccine.2015.01.018_bib0670","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","article-title":"Vaccine-derived poliomyelitis 12 years after infection in Minnesota","volume":"364","author":"DeVries","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.018_bib0675","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/596052","article-title":"Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota","volume":"199","author":"Alexander","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0680","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3201\/eid1806.120037","article-title":"Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011","volume":"18","author":"Gumede","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"785","key":"10.1016\/j.vaccine.2015.01.018_bib0685","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/pgmj.67.785.301","article-title":"Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia","volume":"67","author":"Misbah","year":"1991","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0690","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.inf.0000069792.60744.5b","article-title":"Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child","volume":"22","author":"Hidalgo","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0695","series-title":"Polio Eradication & Endgame Strategic Plan 2013\u20132018. Global Polio Eradication Initiative","year":"2013"},{"issue":"33","key":"10.1016\/j.vaccine.2015.01.018_bib0700","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.vaccine.2014.04.023","article-title":"Polio vaccines: WHO position paper, January 2014 \u2013 recommendations","volume":"32","author":"World Health Organization","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2015.01.018_bib0705","first-page":"468","article-title":"Progress toward polio eradication \u2013 Worldwide, 2013\u20132014","volume":"63","author":"Moturi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"40","key":"10.1016\/j.vaccine.2015.01.018_bib0710","first-page":"874","article-title":"Acute flaccid paralysis associated with circulating vaccine-derived poliovirus \u2013 Philippines, 2001","volume":"50","author":"Center for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.018_bib0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0720","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.coviro.2012.02.006","article-title":"Reaching the last one per cent: progress and challenges in global polio eradication","volume":"2","author":"Kew","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.018_bib0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S095026881000316X","article-title":"Role of environmental poliovirus surveillance in global polio eradication and beyond","volume":"140","author":"Hovi","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2015.01.018_bib0730","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10096-005-1331-9","article-title":"Isolation of vaccine-derived polioviruses in the Slovak Republic","volume":"24","author":"\u010cern\u00e1kov\u00e1","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2015.01.018_bib0735","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.78.9.4876-4883.2004","article-title":"Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia","volume":"78","author":"Blomqvist","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2015.01.018_bib0740","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.38.10.3729-3734.2000","article-title":"Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel","volume":"38","author":"Shulman","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"suppl. 1","key":"10.1016\/j.vaccine.2015.01.018_bib0775","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/infdis\/jiu065","article-title":"Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series","volume":"210","author":"Li","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0750","series-title":"Jeffrey Modell Foundation Announces Global Polio Surveillance Study. Vaccine News","author":"Tinder","year":"2014"},{"issue":"3","key":"10.1016\/j.vaccine.2015.01.018_bib0755","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(97)70199-9","article-title":"Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants","volume":"130","author":"Buckley","year":"1997","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.018_bib0760","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0031-3955(05)70208-X","article-title":"Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States","volume":"47","author":"Sutter","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0765","series-title":"Polio vaccine information","author":"National Travel Health Network and Centre","year":"2004"},{"key":"10.1016\/j.vaccine.2015.01.018_bib0770","series-title":"Vaccines","first-page":"573","article-title":"Poliovirus vaccine\u2014inactivated","author":"Vidor","year":"2012"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T02:08:31Z","timestamp":1598666911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15000377"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: A systematic review and implications for polio eradication","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}